Dynavax Technologies (DVAX) halted ahead of FDA adcom
- Family Dollar Stores (FDO) Rejects Dollar General's (DG) $78.50/Share Bid
- Pre-Open Stock Movers 8/21: (DGLY) (TKMR) (MEET) Higher; (KIN) (AMPE) (KIRK) Lower (more...)
- BofA (BAC) Enters $16.7B Settlement with DoJ Over RMBS Investigation
- Sears Holdings (SHLD) Posts Q2 GAAP Loss of $5.39/Share; Comps Fell 0.1%
- Infineon/International Rectifier (IRF) Seen as Harbinger for More Semi Deals
Dynavax Technologies Corporation (NASDAQ: DVAX) halted ahead of FDA adcom
You May Also Be Interested In
- CLSA Downgrades GT Advanced Tech (GTAT) to Underperform; Analyst Says Poor Yields Could Impact Volume, Costs
- Protalix BioTherapeutics (PLX) Sinks as Sanofi's Gauche Drug Gets Approved
- Traders Eye Hewlett-Packard (HPQ) into Q3 Report
Create E-mail Alert Related CategoriesFDA, Trader Talk, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!